Literature DB >> 4044874

Effect of temperature on antimicrobial susceptibilities of Pseudomonas maltophilia.

P F Wheat, T G Winstanley, R C Spencer.   

Abstract

After a case of peritonitis caused by Pseudomonas maltophilia had occurred 20 strains of the organism were investigated and the minimum inhibitory concentrations of a variety of antibiotics determined at 30 degrees C and 37 degrees C. There was a significant difference in susceptibility between 30 degrees C (most resistant) and 37 degrees C (most susceptible) for aminoglycosides and polymyxin B. No difference was seen with the other agents or in strains of Ps aeruginosa and Enterobacteriaceae tested under similar conditions. The possible mechanisms of this phenomenon are discussed below.

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 4044874      PMCID： PMC499358          DOI： 10.1136/jcp.38.9.1055

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN： 0021-9746            Impact factor:   3.411


  19 in total

1.  Meningitis caused by Pseudomonas maltophilia.

Authors:  S Patrick; J M Hindmarch; R V Hague; D M Harris
Journal:  J Clin Pathol       Date:  1975-09       Impact factor: 3.411

2.  Altered phospholipid metabolism in a temperature-sensitive mutant of Escherichia coli, CR 34 T 46 .

Authors:  R M Bell; R D Mavis; P R Vagelos
Journal:  Biochim Biophys Acta       Date:  1972-08-11

3.  Pseudomonas maltophilia endocarditis after replacement of the mitral valve: a case study.

Authors:  J J Fischer
Journal:  J Infect Dis       Date:  1973-11       Impact factor: 5.226

4.  Nonfermentative bacilli associated with man. 3. Pathogenicity and antibiotic susceptibility.

Authors:  M M Pedersen; E Marso; M J Pickett
Journal:  Am J Clin Pathol       Date:  1970-08       Impact factor: 2.493

5.  Distribution in clinical material and identification of Pseudomonas maltophilia.

Authors:  B Holmes; S P Lapage; B G Easterling
Journal:  J Clin Pathol       Date:  1979-01       Impact factor: 3.411

6.  Letter: Cold-sensitive strain of Pseudomonas aeruginosa from urinary-tract infection.

Authors:  D I Annear; D Macculloch
Journal:  Lancet       Date:  1974-12-07       Impact factor: 79.321

7.  Letter: Temperature-sensitivity and gentamicin-resistance in Pseudomonas aeruginosa.

Authors:  D V Seal; J E Strangeways
Journal:  Lancet       Date:  1975-09-13       Impact factor: 79.321

8.  Susceptibility of Pseudomonas maltophilia to antimicrobial agents, singly and in combination.

Authors:  T P Felegie; V L Yu; L W Rumans; R B Yee
Journal:  Antimicrob Agents Chemother       Date:  1979-12       Impact factor: 5.191

9.  In vitro activity of cefoperazone against nonfermenters and Aeromonas hydrophila.

Authors:  R J Fass
Journal:  Antimicrob Agents Chemother       Date:  1980-09       Impact factor: 5.191

10.  Cefoperazone (T-1551), a new semisynthetic cephalosporin: comparison with cephalothin and gentamicin.

Authors:  R N Jones; P C Fuchs; A L Barry; T L Gavan; H M Sommers; E H Gerlach
Journal:  Antimicrob Agents Chemother       Date:  1980-04       Impact factor: 5.191
View more
  13 in total

1.  Pseudomonas maltophilia.

Authors:  J M Levey
Journal:  J Clin Pathol       Date:  1986-04       Impact factor: 3.411

2.  Synergistic interactions of ciprofloxacin and extended-spectrum beta-lactams or aminoglycosides against multiply drug-resistant Pseudomonas maltophilia.

Authors:  A W Chow; J Wong; K H Bartlett
Journal:  Antimicrob Agents Chemother       Date:  1988-05       Impact factor: 5.191

3.  Occurrence of variants with temperature-dependent susceptibility (TDS) to antibiotics among Stenotrophomonas maltophilia clinical strains.

Authors:  P Hejnar; M Kolár; V Hájek; D Koukalová; P Hamal
Journal:  Folia Microbiol (Praha)       Date:  2001       Impact factor: 2.099

Review 4.  Microbiological and clinical aspects of infection associated with Stenotrophomonas maltophilia.

Authors:  M Denton; K G Kerr
Journal:  Clin Microbiol Rev       Date:  1998-01       Impact factor: 26.132

Review 5.  Antimicrobial therapy for Stenotrophomonas maltophilia infections.

Authors:  A C Nicodemo; J I Garcia Paez
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2007-04       Impact factor: 3.267

6.  Role of phosphoglucomutase of Stenotrophomonas maltophilia in lipopolysaccharide biosynthesis, virulence, and antibiotic resistance.

Authors:  Geoffrey A McKay; Donald E Woods; Kelly L MacDonald; Keith Poole
Journal:  Infect Immun       Date:  2003-06       Impact factor: 3.441

Review 7.  Microbiological aspects of peritonitis associated with continuous ambulatory peritoneal dialysis.

Authors:  A von Graevenitz; D Amsterdam
Journal:  Clin Microbiol Rev       Date:  1992-01       Impact factor: 26.132

8.  Fatty acid analysis of Stenotrophomonas maltophilia clinical strains showing different susceptibility to antibiotics at 30 and 37 degrees C.

Authors:  P Hejnar; Z Chmela; M Rypka
Journal:  Folia Microbiol (Praha)       Date:  2002       Impact factor: 2.099

9.  In vitro activities of antimicrobial combinations against Stenotrophomonas (Xanthomonas) maltophilia.

Authors:  C D Poulos; S O Matsumura; B M Willey; D E Low; A McGeer
Journal:  Antimicrob Agents Chemother       Date:  1995-10       Impact factor: 5.191

10.  Evaluation of the Vitek 2, Phoenix, and MicroScan for Antimicrobial Susceptibility Testing of Stenotrophomonas maltophilia.

Authors:  Ayesha Khan; Cesar A Arias; April Abbott; Jennifer Dien Bard; Micah M Bhatti; Romney M Humphries
Journal:  J Clin Microbiol       Date:  2021-08-18       Impact factor: 5.948
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.